Literature DB >> 10378838

Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.

K B Davis1, S J Slichter, L Corash.   

Abstract

BACKGROUND: Corrected count increment (CCI) and percent platelet recovery (PPR) are measures of response to platelet transfusion that "correct" the count increment for blood volume and number of platelets transfused. Their potential for data distortion is described, and a regression analysis is suggested that is more informative and avoids the inherent problems associated with using ratios as outcome measures. STUDY DESIGN AND METHODS: Data from the first platelet transfusion for 585 patients from the Trial to Reduce Alloimmunization to Platelets (TRAP) were used to model methods of analyzing posttransfusion platelet response.
RESULTS: By linear regression analysis, unfiltered platelet components gave a greater posttransfusion increment on average (p = 0.001), but filtered platelets gave a greater increment per platelet transfused (p = 0.003). In contrast, CCI and PPR showed no difference between filtered and unfiltered platelets (p = 0.36 and p = 0.29, respectively) because they combined the effects of dose, filtration, and patient size. Slightly fewer patients are required for a study analyzed by regression analysis.
CONCLUSION: Regression analysis of posttransfusion platelet increments should be used instead of CCI or PPR to compare the efficacy of platelet components. CCI and PPR should not be used to define platelet refractoriness as a study outcome, because these measures are biased in favor of platelet preparation techniques that provide fewer platelets.

Entities:  

Mesh:

Year:  1999        PMID: 10378838     DOI: 10.1046/j.1537-2995.1999.39060586.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  A copula model for marked point processes.

Authors:  Liqun Diao; Richard J Cook; Ker-Ai Lee
Journal:  Lifetime Data Anal       Date:  2013-05-10       Impact factor: 1.588

2.  Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.

Authors:  Friedgard Julmy; Roland A Ammann; Stefano Fontana; Behrouz Mansouri Taleghani; Andreas Hirt; Kurt Leibundgut
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

3.  Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.

Authors:  Priti Elhence; Rajendra K Chaudhary; Soniya Nityanand
Journal:  Blood Transfus       Date:  2013-11-14       Impact factor: 3.443

4.  The impact of apheresis platelet manipulation on corrected count increment.

Authors:  Matthew Karafin; Alice K Fuller; William J Savage; Karen E King; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2012-01-10       Impact factor: 3.157

5.  Platelet count evolution as a predictor of outcome after splenectomy for immune thrombocytopenic purpura.

Authors:  Moonhwan Kim; Keun Myoung Park; Woo Young Shin; Yun-Mee Choe; Keon-Young Lee; Seung-Ik Ahn
Journal:  Int J Hematol       Date:  2016-10-27       Impact factor: 2.490

6.  HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

Authors:  Ashok Nambiar; Rene J Duquesnoy; Sharon Adams; Yingdong Zhao; Jaime Oblitas; Susan Leitman; David Stroncek; Francesco Marincola
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

7.  Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.

Authors:  Mei Zhu; Wei Xu; Bao-Long Wang; Hong Su
Journal:  Transfus Med Hemother       Date:  2014-05-22       Impact factor: 3.747

8.  Frequency of Platelet Crossmatch Positivity and Predictive Value for Poor Platelet Increment Among Paediatric Oncohaematology Patients in India.

Authors:  Simon Kingsley; Mary Purna Chacko; P Amal; Grace Rebekah; G Mathew Leni; Daniel Dolly
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-25       Impact factor: 0.900

9.  Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.

Authors:  Ravindra Pratap Singh; Neelam Marwaha; Pankaj Malhotra; Sumitra Dash
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

10.  Retrospective cohort studies of repeat donors reveal donor-dependent variability in the recovery of transfused platelets.

Authors:  Jonathan A Stefely; Michael Gailey; Michael Knudson; Larry J Dumont; Thomas J Raife; Noelle I Samia
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.